Continuous multilead ST-monitoring identifies patients with unstable coronary artery disease who benefit from extended antithrombotic treatment.

• Prolongation of anticoagulant treatment might reduce subsequent cardiac events in patients with unstable coronary artery disease. Multilead ST-segment monitoring identifies patients with a high risk of adverse outcome. The aim was to assess the value of multilead ST-monitoring in prospectively identifying patients who respond to extended anticoagulant treatment with low-molecular weight heparin when treated by a primarily non-invasive strategy.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Keyword

Adult

Aged

Aged

80 and over

Angina

Unstable

diagnosis

drug therapy

mortality

Coronary Disease

diagnosis

drug therapy

mortality

Dalteparin

administration & dosage

Dose-Response Relationship

Drug

Drug Administration Schedule

Electrocardiography

Female

Fibrinolytic Agents

administration & dosage

Follow-Up Studies

Humans

Male

Middle Aged

Monitoring

Physiologic

methods

Severity of Illness Index

Survival Rate

Time Factors

Treatment Outcome

Adult

Publication and Content Type

ref (subject category)

art (subject category)